Diagnostic potential of serum proteomic patterns in prostate cancer.
暂无分享,去创建一个
Bao-Ling Adam | Amina Ali | J. Moul | S. Srivastava | B. Adam | D. Mcleod | L. Bañez | P. Prasanna | Z. Zou | Shiv Srivastava | David G McLeod | Judd W Moul | Leon Sun | Zhiqiang Zou | Lionel L Bañez | Premkala Prasanna | Leon L Sun | Amina Ali
[1] E. Petricoin,et al. Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.
[2] O John Semmes,et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] Dr. Ron Short. Diagnosis? , 1987, The Lancet.
[4] G. Wright,et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. , 2001, The American journal of pathology.
[5] Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). , 2000, Oncology.
[6] E. Petricoin,et al. Serum proteomic patterns for detection of prostate cancer. , 2002, Journal of the National Cancer Institute.
[7] M. Barry. Prostate-Specific–Antigen Testing for Early Diagnosis of Prostate Cancer , 2001 .
[8] S. Ethier,et al. Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis. , 2001, Analytical chemistry.
[9] P. Schellhammer,et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. , 2002, Cancer research.
[10] D. Chan,et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.
[11] S R Gullans,et al. DNA microarray analysis of complex biologic processes. , 2001, Journal of the American Society of Nephrology : JASN.
[12] Uwe Claussen,et al. Mass spectrometry meets chip technology: A new proteomic tool in cancer research? , 2001, Electrophoresis.
[13] M. Barry,et al. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. , 2001, The New England journal of medicine.
[14] Paulo J. G. Lisboa,et al. A review of evidence of health benefit from artificial neural networks in medical intervention , 2002, Neural Networks.
[15] T. Golub,et al. DNA microarrays in clinical oncology. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] T. Keough,et al. Tandem mass spectrometry methods for definitive protein identification in proteomics research , 2000, Electrophoresis.
[17] B. Weber,et al. Cancer genomics. , 2002, Cancer cell.
[18] M. Lise,et al. Protein profiles in sera of patients with malignant cutaneous melanoma. , 2000, Rapid communications in mass spectrometry : RCM.
[19] Sarunas Raudys. How good are support vector machines? , 2000, Neural Networks.
[20] Ahmedin Jemal,et al. Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.